An interventional study of Education in Infant Death, Infant Care and Midwifery, sponsored by Cukurova University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-20.
Sponsored by Cukurova University · Not applicable, Interventional, and Prevention
This project is a pioneering study in determining the impact of midwife-led safe infant care training for pregnant women on awareness of sudden infant death syndrome (SIDS) and home accidents. Raising awareness and improving women's knowledge about SIDS and home accidents is expected to help reduce preventable infant deaths. If the effectiveness of this training is proven, integrating it into prenatal care programs would be a significant step towards improving maternal and child health.
This research is designed as a randomized controlled experimental study. The research will be conducted in the NST unit located in the Marsa Obstetrics and Gynecology Annex Building of Seyhan State Hospital between the specified dates. It has been determined that 60 participants should be included in the intervention group and 60 in the control group. Primiparous pregnant women ≥32 weeks of gestation will be included in the study. The study will be conducted in two interviews. The pre-test will be administered at the first meeting with the pregnant woman, and the post-test will be administered in the second week postpartum. The independent variables of the study are safe infant care education, and the demographic and obstetric characteristics of the pregnant women. The dependent variables are awareness of sudden infant death syndrome and scores on the home accident awareness scale for mothers. After normality tests are performed, univariate and multivariate analyses appropriate to the data set will be performed, and a significance level of p\<0.05 will be considered. The Statistical Programme for Social Science 22 (SPSS) will be used for data analysis.
51 studies on the registry are indexed under Infant Death; 15 are open to participants now.
This study's planned enrollment of 120 is below the median of 4,287 across 40 interventional studies indexed under Infant Death.
Browse Infant Death studies →Cukurova University is the lead sponsor of 259 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Following the pre-test, the intervention group will receive training on safe infant care. A final test will be administered via telephone in the second week postpartum.
Other: Education
Standard care (Turkish Ministry of Health Prenatal Care Guide) will be applied during the follow-up care after the pre-test. A final test will be administered via telephone in the second week postpartum.
The educational content consists of general information about sudden infant death syndrome and home accidents in children aged 0-3, as well as prevention methods.
Home Accident Awareness Scale for Mothers
Items are scored on a scale of 1-5. As the scale score increases, mothers' awareness of household accidents will increase.
Time frame: pre-intervention, immediately after the intervention, after 2 week
Sudden Infant Death Syndrome Awareness Scale - Mother Form
Items are scored on a scale of 1 to 5. As the score obtained from the scale increases, the awareness score decreases.
Time frame: pre-intervention, immediately after the intervention, after 2 week
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Feb 2026; primary completion for Dec 2026, 10 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.